EUVIMEDEUVIMED entdecken
Crossref

Research Progress of BTG2 as a Tumor Prognostic Factor

Yang Wanting, Yang Peizheng, Li Yan, Yang Yinfeng, Wang Jinghui

Archives of Cancer Science and Therapy · 2023

DOI: 10.29328/journal.acst.1001036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Cancer Science and Therapy, 2023. Verfasst von Yang Wanting und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a major public health issue and the main cause of death worldwide. Despite improvements in diagnostic techniques and treatment methods, cancer still seriously affects the quality of life of patients, which cause serious social and economic burdens. Therefore, there is an urgent need to identify potential biomarkers to improve diagnosis, treatment, and prognosis of cancer. BTG2 is a cell proliferation suppressor gene that serves as a tumor suppressor gene in the occurrence and development of various tumors. Many studies have shown that BTG2 can serve as a prognostic marker in various tumors. So, fully tap the potentials of BTG2 as a tumor prognostic marker will bring more possibilities to provide a new method or new diagnostic and therapeutic tool for treating cancer.

Zitieren

APA

Wanting, Y., Peizheng, Y., Yan, L., Yinfeng, Y., & Jinghui, W. (2023). Research Progress of BTG2 as a Tumor Prognostic Factor. Archives of Cancer Science and Therapy. https://doi.org/10.29328/journal.acst.1001036

Vancouver

Wanting Y, Peizheng Y, Yan L, Yinfeng Y, Jinghui W. Research Progress of BTG2 as a Tumor Prognostic Factor. Archives of Cancer Science and Therapy. 2023. doi:10.29328/journal.acst.1001036

BibTeX
@article{Wanting2023,
  author = {Wanting, Yang and Peizheng, Yang and Yan, Li and Yinfeng, Yang and Jinghui, Wang},
  title = {Research Progress of BTG2 as a Tumor Prognostic Factor},
  journal = {Archives of Cancer Science and Therapy},
  year = {2023},
  doi = {10.29328/journal.acst.1001036}
}
Kostenlos starten →